New award for pantoprazole tablets with xlcare pharmaceuticals. Ordering period is june 26, 2022 to june 25, 2023 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0023
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 87% complete
IDV ceiling
$28,973,375.80
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a single-award indefinite-delivery contract to Xlcare Pharmaceuticals Inc. for pantoprazole tablets, with a ceiling of $28,973,375.80, effective June 26, 2022. Xlcare Pharmaceuticals is an economically disadvantaged woman-owned small business.

The contract supplies delayed-release pantoprazole tablets in 20mg and 40mg dosages to the Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service. Estimated annual requirements total 160,011 bottles of 20mg pantoprazole, 687,323 bottles of 40mg pantoprazole, and 47,921 bottles of 40mg pantoprazole in 1000-count bottles. The NAICS code is 325412.

The base ordering period runs from June 26, 2022 through June 25, 2023, with four one-year options extending the ultimate completion date to June 25, 2027. The contract was awarded under FAR Part 12 procedures and implements Executive Order 14398 regarding diversity, equity, and inclusion in federal contracting.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · Implementing EO 14398 DEI discrimination $0
Exercise an Option P00006 · This modification is issued to exercise the 4TH option year for pantoprazole tablets under contract 36E79722D0023. $0
Exercise an Option P00005 · This modification is issued to exercise the 3RD option year for pantoprazole tablets under contract 36E79722D0023. $0
Exercise an Option P00004 · This modification is issued to exercise the 2ND option year for pantoprazole tablets under contract 36E79722D0023. $0
Supplemental Agreement for work within scope P00003 · This modification is issued to update the terms of the CRF payment remittal and submission of quarterly sales reports. $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 for pantoprazole tablets under contract 36E79722D0023 with xlcare pharmaceuticals INC. For the period of… $0
Other Administrative Action P00001 · This modification is issued to incorporate the drug supply chain security act (DSCSA) language into the contract. $0
Original award $0

Quick answers

Who was awarded contract 36E79722D0023?

36E79722D0023 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on June 26, 2022.

How much is contract 36E79722D0023 worth?

36E79722D0023's own ceiling is $28,973,376.

Who can order from contract 36E79722D0023?

36E79722D0023 is a single award indefinite delivery contract.

Was contract 36E79722D0023 competed?

The extent of competition for 36E79722D0023 was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV